Author： Adis International Limited
Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.5, Iss.3, 2004-01, pp. : 164-165
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Idraparinux sodium effective for DVT, but not PE
Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. :
Access to resources
Recommend
Idraparinux effective, but risky, for venous thromboembolism
Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. :
Increased haemorrhage risk with idraparinux leads to trial termination
Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. :
Idraparinux risky for embolism prevention in AF patients
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :